CAS 183321-74-6 appears in our catalog under these names: N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, >95% (HPLC), Erlotinib, >95% (HPLC), Erlotinib/ 99.94% (existing batch purity), Erlotinib, Erlotinib base. Offered by: TRC, TargetMol, GLPBio, Biosynth, TCI. Available pack sizes: 1g, 25g, 500mg, 50mg, 100mg, 10mM (in 1ml dmso), 5g, 50g.
Erlotinib is a quinazoline compound having a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions. It has a role as an antineoplastic agent, a protein kinase inhibitor and an epidermal growth factor receptor antagonist. It is an aromatic ether, a member of quinazolines, a secondary amino compound and a terminal acetylenic compound.
Source: ChEBI
| Molecular formula | C22H23N3O4 |
|---|---|
| Molecular weight | 393.4 g/mol |
| IUPAC name | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
| InChIKey | AAKJLRGGTJKAMG-UHFFFAOYSA-N |
| SMILES | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC |
Computed by PubChem (NCBI)